Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MYND Life Sciences C.MYND

Alternate Symbol(s):  MYNDF

MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

MYND Life Sciences celebrates Dr. Wilf Jefferies milestone

MYND Life Sciences celebrates Dr. Wilf Jefferies induction as a National Academy of Inventors Fellow  rate and reply

MYND announces innovation in psilocybin dosing  rate and reply

MYND Life Sciences announces private placement  rate and reply

Participation in a Monash University (Australia) Proposal

 Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression VANCOUVER, BC, Oct. 13, 2021 /CNW/ - MYND Diagnostics Inc., a more

Big potential in Pyschedelic Names $MYND $CBDX $LVT

Big potential in Pyschedelic Names $MYND $CBDX $LVT  rate and reply

Report on Adastra Thoughts? Never heard of this website before.  rate and reply

MYND Life Sciences #Repost #news

MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering $MYND  rate and reply


$MYND, these guys out of all thepyshceldic companies running clinical trials have some of the best chances for near term revenue with their biomarker.  rate and reply

About to be Cashed Up and ready to go!

Nice to see this after several weeks of almost no action on this stock. This now gives them the money to continue their research but also inject some new life into market. What they're working more

DTC Eligibility

VANCOUVER, BC, Aug. 11, 2021 /PRNewswire/ - MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) ("MYND") is a drug research and development company focused more

The trials these guys are working on are amazing

  rate and reply

3 min clip describing the 4 key patents of MYND

Honestly cant say enough how much I hope they're successful with treating and regressing Alzheimer's disease. It would legit by life changing for so many elderly people in their later years more

Joined the Team

looking at this... this could be an amazing journey....  putting a couple of hundred a week into the MYND... instead of chasing stocks lol could you imagine the possibilites... more

Great corporate recap interview from their CEO

This sh*t excites the hell out of me. Coming from someone whos grandpa went through Alzhymer's, if they can treat it AND prove regression in humans (theyve done so in mice) then this is one of more

Now Alzheimers and Dementia lanes!

Love  seeing these guys expand their psych medicine science into Alzheimer's disease and Dementia. Two incredibly sad things to happen to a human as they age. If we can find a solution more

This is such a sleeper psych play

I cant wait for more eyes to come onto this play. These guys are looking to change the game by having no psychoactive effects from their psilocybin drug against depression. They just need to get more